Skip to content

Effectiveness of Enhanced Recovery After Surgery (ERAS) Protocol in Open Benign Gynecologic Surgery: A Randomized Controlled Trial

Effectiveness of Enhanced Recovery After Surgery (ERAS) Protocol in Open Benign Gynecologic Surgery: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260420006
Enrollment
114
Registered
2026-04-20
Start date
2026-04-08
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign gynecologic conditions requiring open transabdominal hysterectomy (TAH) Enhanced Recovery After Surgery (ERAS), Open Benign Gynecologic Surgery, Transabdominal Hysterectomy (TAH), Length of Hospital Stay (LOS), Postoperative Recover, Randomized Controlled Trial (RCT)

Interventions

ERAS protocols should be structured around three major phases: preoperative, intraoperative, and postoperative care. Preoperative strategies focus on patient education, optimization of comorbidities,
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery
ERAS intervention ,standard perioperative care

Sponsors

Lampang Hospital, Thailand
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Adult female patients aged 18-65 years 2. Undergoing open transabdominal hysterectomy (TAH) for benign gynecologic conditions (e.g., Myoma uteri, Adenomyosis, Endometriosis, Ovarian tumor) 3. Patients with an American Society of Anesthesiologists (ASA) physical status classification I-II 4. Patients who capable of giving informed consent and following ERAS protocol

Exclusion criteria

Exclusion criteria: 1. Emergency surgeries (e.g., For twisted, hemorrhage, or ruptured) 2. Pregnant patients 3. Patients with pre-existing bowel obstruction or significant gastrointestinal motility disorders 4. Patients with history of hypersensitivity or contraindication to NSAIDs 5. Patients with history of chronic opioids or substances use

Design outcomes

Primary

MeasureTime frame
Length of Stay (LOS) the time interval starting from the patient is entry into the operating room (Time in) until the time when the patient fulfills all predefined discharge criteria Days

Secondary

MeasureTime frame
Time to first oral intake the time interval starting from the patient is entry into the operating room (Time in) until the time when the patient tolerates oral fluids or the soft or regular diet Hours,Time to first flatus or defecation the time interval starting from the patient is entry into the operating room (Time in) until the time when the patient is first flatus or first defecation (whichever occurs first) Hours,Time to first ambulation the time interval starting from the patient is entry into the operating room (Time in) until the time when the patient is able to sit out of bed or walk independently or with minimal assistance Hours,Postoperative pain scores at 6, 24 and 48 hr postoperatively Visual Analogue Scale (VAS),Postoperative nacrotic consumptions Cumulative postoperative opioid consumption until the patient meets standardized discharge criteria Morphine milligram equivalent, mg,Postoperative complications Within 30 days after surgery Clavien-Dindo classification,Hospital re-visit and re-admission Within 30 days after surgery Incidence of hospital revisit or readmission. Data will be collected from electronic medical records,Patient satisfaction at discharge At the time of hospital discharge 5-point Likert scale

Countries

Thailand

Contacts

Public ContactNapitch Leelathanapipat

Lampang Hospital

Napitch2000@gmail.com054237400

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026